Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.

Engeli S, May M, Nussberger J, Danser AHJ, Dole WP, Prescott MF, Dahlke M, Stitah S, Pal P, Boschmann M, Jordan J.

J Am Soc Hypertens. 2017 Aug;11(8):488-497. doi: 10.1016/j.jash.2017.06.002. Epub 2017 Jun 12.

PMID:
28666704
2.

Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients.

Boschmann M, Nussberger J, Engeli S, Danser AH, Yeh CM, Prescott MF, Dahlke M, Jordan J.

J Hypertens. 2012 Mar;30(3):561-6. doi: 10.1097/HJH.0b013e32834f6b43.

PMID:
22278138

Supplemental Content

Loading ...
Support Center